Followers | 68 |
Posts | 2025 |
Boards Moderated | 0 |
Alias Born | 09/27/2011 |
Saturday, December 23, 2017 3:48:49 PM
And my understanding about their technological advances differs somewhat from you and your admittedly skeptical "scientific chums" ..... though we have one positive thing in common ..... I have been a major supporter of $PLU? Power since hearing their CEO give an NPR radio interview during the summer of 1998 ..... The man was very articulate indeed ..... indicating a significant degree of creative genius ..... I realized then they were worth following ..... though I have been somewhat distracted lately .....
You seem to minimize or overlook the fact that commercial applications for the electricity-generating $WNDW technology have been made ready for installation and apparent commercial applications .....
I have to wonder exactly who might the competition be in this space ? ..... And why ? .... If $WNDW looks to be a technology giant of the future ..... Then why would one of the "MAJORS" not want to buy them out to help capture greater Market share ? ..... Especially when the "majors" have access to substantial funding ? ..... I´m willing to bet the CEO of $PLU? sees the possible exponential upside growth-potential of $WNDW .....
Best Wishes
Recent WNDW News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 08:09:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 08:48:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/21/2023 10:23:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 08:25:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 08:23:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 08:21:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/30/2023 08:27:12 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM